Aurobindo Pharma Board approves ₹800 cr share buyback plan
7 April 20261 min read0 views
Generic drugmaker is proposing to buyback more than 54.23 lakh equity shares at ₹1,475 each, fixes April 17, 2026 as the record date
Related Articles
0EV retail sales in India up 24.6% at 24.52 lakh units in FY26: FADA
While electric two-wheelers crossed 14 lakh units, electric passenger vehicle retail sales missed the two lakh units by a whisker but surged 83.63% in...
The Hindu
3 days ago3
0Stock markets rally for fourth day; Sensex jumps over 500 points
From the 30-Sensex firms, Tata Consultancy Services, HCL Tech, Infosys, Bharti Airtel, Sun Pharma, and Hindustan Unilever were among the major gainers
The Hindu
3 days ago3
0Rupee falls 10 paise to close at 93 against USD
Forex traders said the USD/INR pair is trading under pressure, dragged down by unabated withdrawal of foreign capital, a firm dollar, and higher crude...
The Hindu
3 days ago3
0Campbell Wilson says Air India tenure is highlight of his 30-year aviation career
The tenure of Air India's outgoing CEO Campbell Wilson is marked by wins on the ground and in the air, except India's deadliest plane crash in June la...
Hindustan Times
3 days ago3